A novel inhibitor of the NF-κB signaling pathway encoded by the parapoxvirus orf virus

Journal of Virology

Volumn 84, Issue 8, 2010, Pages 3962-3973

  Diel, D G ^a,b   Delhon, G ^c   Luo, S ^a   Flores, E F ^b   Rock, D L ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b Centro de Ciências Rurais   (Brazil)

^c UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN P65; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS PROTEIN ORFV024; CHEMOKINE; I KAPPA B; I KAPPA B KINASE; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; VIRULENCE FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOPLASM; DISEASE SEVERITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NATURAL HOST; NONHUMAN; NUCLEOTIDE SEQUENCE; PARAPOXVIRUS; POXVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REPORTER GENE; SEQUENCE HOMOLOGY; SHEEP; VIRUS PLAQUE; VIRUS REPLICATION; VIRUS VIRULENCE; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CONTAGIOUS ECTHYMA; DRUG ANTAGONISM; GENE DELETION; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; POXVIRUS; SIGNAL TRANSDUCTION; VIROLOGY;

ANIMALIA; CAPRA HIRCUS; ORF VIRUS; OVIS; OVIS ARIES; PARAPOXVIRUS;

ANIMALS; CELLS, CULTURED; CHEMOKINES; ECTHYMA, CONTAGIOUS; GENE DELETION; I-KAPPA B KINASE; I-KAPPA B PROTEINS; NF-KAPPA B; ORF VIRUS; PHOSPHORYLATION; SHEEP; SIGNAL TRANSDUCTION; VIRAL PROTEINS; VIRULENCE FACTORS;

EID: 77950507119     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02291-09     Document Type: Article

References (70)

1. Assarsson, E., J. A. Greenbaum, M. Sundstrom, L. Schaffer, J. A. Hammond, V. Pasquetto, C. Oseroff, R. C. Hendrickson, E. J. Lefkowitz, D. C. Tscharke, J. Sidney, H. M. Grey, S. R. Head, B. Peters, and A. Sette. 2008. Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes. Proc. Natl. Acad. Sci. U. S. A. 105: 2140-2145.
2. Bartlett, N., J. A. Symons, D. C. Tscharke, and G. L. Smith. 2002. The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence. J. Gen. Virol. 83: 1965-1976.
3. Bowie, A., E. Kiss-Toth, J. A. Symons, G. L. Smith, S. K. Dower, and L. A. O'Neill. 2000. A46R and A52R from vaccinia virus are antagonists of host IL-1 and Toll-like receptor signaling. Proc. Natl. Acad. Sci. U. S. A. 97: 10162-10167.
4. Buss, H., A. Dorrie, M. L. Schmitz, E. Hoffmann, K. Resch, and M. Kracht. 2004. Constitutive and interleukin-1-inducible phosphorylation of p65 NF-κB at serine 536 is mediated by multiple protein kinases including IκB kinase (IKK)-alpha, IKKbeta, IKKepsilon, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. J. Biol. Chem. 279: 55633-55643.
5. Buttner, M. 1993. Principles of paramunization. Option and limits in veterinary medicine. Comp. Immunol. Microbiol. Infect. Dis. 16: 1-10.
6. Camus-Bouclainville, C., L. Fiette, S. Bouchiha, B. Pignolet, D. Counor, C. Filipe, J. Gelfi, and F. Messud-Petit. 2004. A virulence factor of myxoma virus colocalizes with NF-κB in the nucleus and interferes with inflammation. J. Virol. 78: 2510-2516.
7. Castrucci, G., M. Ferrari, B. I. Osburn, F. Frigeri, F. Barreca, S. Tagliati, and V. Cuteri. 1995. The use of a nonspecific defense mechanism inducer in calves exposed to bovine herpesvirus-1 infection: preliminary trials. Comp. Immunol. Microbiol. Infect. Dis. 18: 85-91.
8. Chen, F., L. M. Demers, and X. Shi. 2002. Upstream signal transduction of NF-κB activation. Curr. Drug Targets Inflamm. Allergy 1: 137-149.
9. Chen, L. F., and W. C. Greene. 2004. Shaping the nuclear action of NF-κB. Nat. Rev. Mol. Cell. Biol. 5: 392-401.
10. Chen, R. A., N. Jacobs, and G. L. Smith. 2006. Vaccinia virus strain Western Reserve protein B14 is an intracellular virulence factor. J. Gen. Virol. 87: 1451-1458.
11. Chen, R. A., G. Ryzhakov, S. Cooray, F. Randow, and G. L. Smith. 2008. Inhibition of IκB kinase by vaccinia virus virulence factor B14. PLoS Pathog. 4: e22.
12. Chisholm, S. E., and H. T. Reyburn. 2006. Recognition of vaccinia virusinfected cells by human natural killer cells depends on natural cytotoxicity receptors. J. Virol. 80: 2225-2233.
13. de la Concha-Bermejillo, A., J. Guo, Z. Zhang, and D. Waldron. 2003. Severe persistent orf in young goats. J. Vet. Diagn. Invest. 15: 423-431.
14. Delhon, G., E. R. Tulman, C. L. Afonso, Z. Lu, A. de la Concha-Bermejillo, H. D. Lehmkuhl, M. E. Piccone, G. F. Kutish, and D. L. Rock. 2004. Genomes of the parapoxviruses ORF virus and bovine papular stomatitis virus. J. Virol. 78: 168-177.
15. DiPerna, G., J. Stack, A. G. Bowie, A. Boyd, G. Kotwal, Z. Zhang, S. Arvikar, E. Latz, K. A. Fitzgerald, and W. L. Marshall. 2004. Poxvirus protein N1L targets the I-κB kinase complex, inhibits signaling to NF-κB by the tumor necrosis factor superfamily of receptors, and inhibits NF-κB and IRF3 signaling by Toll-like receptors. J. Biol. Chem. 279: 36570-36578.
16. Dvoracek, B., and T. Shors. 2003. Construction of a novel set of transfer vectors to study vaccinia virus replication and foreign gene expression. Plasmid 49: 9-17.
17. Erickson, G. A., E. A. Carbrey, and G. A. Gustafson. 1975. Generalized contagious ecthyma in a sheep rancher: diagnostic considerations. J. Am. Vet. Med. Assoc. 166: 262-263.
18. Fachinger, V., T. Schlapp, and A. Saalmuller. 2000. Evidence for a parapox ovis virus-associated superantigen. Eur. J. Immunol. 30: 2962-2971.
19. Fachinger, V., T. Schlapp, W. Strube, N. Schmeer, and A. Saalmuller. 2000. Poxvirus-induced immunostimulating effects on porcine leukocytes. J. Virol. 74: 7943-7951.
20. Fleming, S. B., D. M. Haig, P. Nettleton, H. W. Reid, C. A. McCaughan, L. M. Wise, and A. Mercer. 2000. Sequence and functional analysis of a homolog of interleukin-10 encoded by the parapoxvirus orf virus. Virus Genes 21: 85-95.
21. Fleming, S. B., and A. A. Mercer. 2007. Genus Parapoxvirus, p. 127-165. In A. A. Mercer, A. Schmidt, and O. Weber (ed.), Poxviruses. Birkhäuser, Basel, Switzerland.
22. Friebe, A., A. Siegling, S. Friederichs, H. D. Volk, and O. Weber. 2004. Immunomodulatory effects of inactivated parapoxvirus ovis (ORF virus) on human peripheral immune cells: induction of cytokine secretion in monocytes and Th1-like cells. J. Virol. 78: 9400-9411.
23. Gautier, L., L. Cope, B. M. Bolstad, and R. A. Irizarry. 2004. Affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20: 307-315.
24. Gedey, R., X. L. Jin, O. Hinthong, and J. L. Shisler. 2006. Poxviral regulation of the host NF-κB response: the vaccinia virus M2L protein inhibits induction of NF-κB activation via an ERK2 pathway in virus-infected human embryonic kidney cells. J. Virol. 80: 8676-8685.
25. Gentleman, R. C., V. J. Carey, D. M. Bates, B. Bolstad, M. Dettling, S. Dudoit, B. Ellis, L. Gautier, Y. Ge, J. Gentry, K. Hornik, T. Hothorn, W. Huber, S. Iacus, R. Irizarry, F. Leisch, C. Li, M. Maechler, A. J. Rossini, G. Sawitzki, C. Smith, G. Smyth, L. Tierney, J. Y. Yang, and J. Zhang. 2004. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5: R80.
26. Graham, S. C., M. W. Bahar, S. Cooray, R. A. Chen, D. M. Whalen, N. G. Abrescia, D. Alderton, R. J. Owens, D. I. Stuart, G. L. Smith, and J. M. Grimes. 2008. Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-κB rather than apoptosis. PLoS Pathog. 4: e1000128.
27. Guo, J., Z. Zhang, J. F. Edwards, R. W. Ermel, C. Taylor, Jr., and A. de la Concha-Bermejillo. 2003. Characterization of a North American orf virus isolated from a goat with persistent, proliferative dermatitis. Virus Res. 93: 169-179.
28. Haig, D. M., and C. J. McInnes. 2002. Immunity and counter-immunity during infection with the parapoxvirus orf virus. Virus Res. 88: 3-16.
29. Haig, D. M., and A. A. Mercer. 1998. Ovine diseases. Orf. Vet. Res. 29: 311-326.
30. Harte, M. T., I. R. Haga, G. Maloney, P. Gray, P. C. Reading, N. W. Bartlett, G. L. Smith, A. Bowie, and L. A. O'Neill. 2003. The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J. Exp. Med. 197: 343-351.
31. Hiscott, J., T. L. Nguyen, M. Arguello, P. Nakhaei, and S. Paz. 2006. Manipulation of the nuclear factor-κB pathway and the innate immune response by viruses. Oncogene 25: 6844-6867.
32. Iketani, Y., Y. Inoshima, A. Asano, K. Murakami, S. Shimizu, and H. Sentsui. 2002. Persistent parapoxvirus infection in cattle. Microbiol. Immunol. 46: 285-291.
33. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18: 621-663.
34. Kawai, T., and S. Akira. 2007. Signaling to NF-κB by Toll-like receptors. Trends Mol. Med. 13: 460-469.
35. Kuroda, Y., M. Yoshida, T. Shibahara, T. Matsui, T. Nakane, H. Hara, Y. Inoshima, and H. Sentsui. 1999. An epidemic of parapoxvirus infection among cattle: isolation and antibody survey. J. Vet. Med. Sci. 61: 749-753.
36. Lawrence, T., M. Bebien, G. Y. Liu, V. Nizet, and M. Karin. 2005. IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation. Nature 434: 1138-1143.
37. Matta, H., R. M. Surabhi, J. Zhao, V. Punj, Q. Sun, S. Schamus, L. Mazzacurati, and P. M. Chaudhary. 2007. Induction of spindle cell morphology in human vascular endothelial cells by human herpesvirus 8-encoded viral FLICE inhibitory protein K13. Oncogene 26: 1656-1660.
38. Mayr, A., M. Buttner, G. Wolf, H. Meyer, and C. Czerny. 1989. Experimental detection of the paraspecific effects of purified and inactivated poxviruses. Zentralbl. Veterinarmed. B 36: 81-99.
39. Mazur, C., and R. D. Machado. 1989. Detection of contagious pustular dermatitis virus of goats in a severe outbreak. Vet. Rec. 125: 419-420.
40. McKeever, D. J., D. M. Jenkinson, G. Hutchison, and H. W. Reid. 1988. Studies of the pathogenesis of orf virus infection in sheep. J. Comp. Pathol. 99: 317-328.
41. Mohamed, M. R., and G. McFadden. 2009. NFκB inhibitors: strategies from poxviruses. Cell Cycle 8: 3125-3132.
42. Mohamed, M. R., M. M. Rahman, A. Rice, R. W. Moyer, S. J. Werden, and G. McFadden. 2009. Cowpox virus expresses a novel ankyrin repeat NF-κB inhibitor that controls inflammatory cell influx into virus-infected tissues and is critical for virus pathogenesis. J. Virol. 83: 9223-9236.
43. Moss, B. 2007. Poxviruses: the viruses and their replication, p. 2905-2946. In D. M. Knipe and P. M. Howley (ed.), Fields virology, vol. 2. Wolters Kluwer Health/Lippincott/The Williams & Wilkins Co., Philadelphia, PA.
44. Mourtada, I., M. Le Tourneur, J. Chevrant-Breton, and F. Le Gall. 2000. Human orf and erythema multiforme. Ann. Dermatol. Venereol. 127: 397-399.
45. Murao, L. E., and J. L. Shisler. 2005. The MCV MC159 protein inhibits late, but not early, events of TNF-alpha-induced NF-κB activation. Virology 340: 255-264.
46. Myskiw, C., J. Arsenio, R. van Bruggen, Y. Deschambault, and J. Cao. 2009. Vaccinia virus E3 suppresses expression of diverse cytokines through inhibition of the PKR, NF-κB, and IRF3 pathways. J. Virol. 83: 6757-6768.
47. Nakamichi, K., M. Saiki, H. Kitani, Y. Kuboyama, K. Morimoto, M. Takayama-Ito, and I. Kurane. 2007. Roles of NF-κB and MAPK signaling pathways in morphological and cytoskeletal responses of microglia to double-stranded RNA. Neurosci. Lett. 414: 222-227.
48. Ndikuwera, J., G. O. Odiawo, E. A. Usenik, N. D. Kock, J. S. Ogaa, and R. Kuiper. 1992. Chronic contagious ecthyma and caseous lymphadenitis in two Boer goats. Vet. Rec. 131: 584-585.
49. Nettleton, P. F., J. A. Gilray, D. L. Yirrell, G. R. Scott, and H. W. Reid. 1996. Natural transmission of orf virus from clinically normal ewes to orf-naive sheep. Vet. Rec. 139: 364-366.
50. Nichols, D. B., and J. L. Shisler. 2009. Poxvirus MC160 protein utilizes multiple mechanisms to inhibit NF-κB activation mediated via components of the tumor necrosis factor receptor 1 signal transduction pathway. J. Virol. 83: 3162-3174.
51. Pahl, H. L. 1999. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18: 6853-6866.
52. Perkins, N. D. 2007. Integrating cell-signalling pathways with NF-κB and IKK function. Nat. Rev. Mol. Cell. Biol. 8: 49-62.
53. Perkins, N. D. 2006. Post-translational modifications regulating the activity and function of the nuclear factor κB pathway. Oncogene 25: 6717-6730.
54. Sakurai, H., H. Chiba, H. Miyoshi, T. Sugita, and W. Toriumi. 1999. IκB kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 274: 30353-30356.
55. Sanchez, R. L., A. Hebert, H. Lucia, and J. Swedo. 1985. Orf. A case report with histologic, electron microscopic, and immunoperoxidase studies. Arch. Pathol. Lab. Med. 109: 166-170.
56. Santoro, M. G., A. Rossi, and C. Amici. 2003. NF-κB and virus infection: who controls whom. EMBO J. 22: 2552-2560.
57. Scheidereit, C. 2006. IκB kinase complexes: gateways to NF-κB activation and transcription. Oncogene 25: 6685-6705.
58. Sentsui, H., K. Murakami, Y. Inoshima, T. Shibahara, and Y. Yokomizo. 1999. Isolation of parapoxvirus from a cow treated with interferon-gamma. Vet. Microbiol. 70: 143-152.
59. Shisler, J. L., and X. L. Jin. 2004. The vaccinia virus K1L gene product inhibits host NF-κB activation by preventing IκBα degradation. J. Virol. 78: 3553-3560.
60. Siegemund, S., A. Hartl, H. von Buttlar, F. Dautel, R. Raue, M. A. Freudenberg, G. Fejer, M. Buttner, G. Kohler, C. J. Kirschning, T. Sparwasser, and G. Alber. 2009. Conventional bone marrow-derived dendritic cells contribute to Toll-like receptor-independent production of alpha/beta interferon in response to inactivated parapoxvirus ovis. J. Virol. 83: 9411-9422.
61. Smith, G. L. 2007. Genus Orthopoxvirus: vaccinia virus, p. 1-45. In A. A. Mercer, A. Schmidt, and O. Weber (ed.), Poxviruses. Birkhäuser, Basel, Switzerland.
62. Stack, J., I. R. Haga, M. Schroder, N. W. Bartlett, G. Maloney, P. C. Reading, K. A. Fitzgerald, G. L. Smith, and A. G. Bowie. 2005. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J. Exp. Med. 201: 1007-1018.
63. Unterholzner, L., and A. G. Bowie. 2008. The interplay between viruses and innate immune signaling: recent insights and therapeutic opportunities. Biochem. Pharmacol. 75: 589-602.
64. Weber, O., P. Knolle, and H. D. Volk. 2007. Immunomodulation by inactivated Orf virus (ORFV) : therapeutic potential, p. 297-310. In A. A. Mercer, A. Schmidt, and O. Weber (ed.), Poxviruses. Birkhäuser, Basel, Switzerland.
65. Wertz, I. E., and V. M. Dixit. 2008. Ubiquitin-mediated regulation of TNFR1 signaling. Cytokine Growth Factor Rev. 19: 313-324.
66. Westphal, D., E. C. Ledgerwood, M. H. Hibma, S. B. Fleming, E. M. Whelan, and A. A. Mercer. 2007. A novel Bcl-2-like inhibitor of apoptosis is encoded by the parapoxvirus ORF virus. J. Virol. 81: 7178-7188.
67. Wong, M. L., and J. F. Medrano. 2005. Real-time PCR for mRNA quantitation. Biotechniques 39: 75-85.
68. Wu, Z., and R. A. Irizarry. 2005. Stochastic models inspired by hybridization theory for short oligonucleotide arrays. J. Comput. Biol. 12: 882-893.
69. Yirrell, D. L., H. W. Reid, M. Norval, and S. E. Howie. 1989. Immune response of lambs to experimental infection with Orf virus. Vet. Immunol. Immunopathol. 22: 321-332.
70. Ziebell, K. L., H. Steinmann, D. Kretzdorn, T. Schlapp, K. Failing, and N. Schmeer. 1997. The use of Baypamun N in crowding associated infectious respiratory disease: efficacy of Baypamun N (freeze-dried product) in 4-10 month old horses. Zentralbl. Veterinarmed. B 44: 529-536.